PGX

clinpgx-2024-agenda.pdf

03 - Preemptive Return of Clinical Pharmacogenomic Results to Over 50,000 Individuals in a Population-scale Biobank: Phenotype and Actionable Medication Exposure Characteristics James L Martin, PharmD , MPH1,2, Kristy R Crooks, PhD1, 3, Casey S Greene, PhD1,3, Ashley Hansen, RN, BSN4, Emily C Hearst, MHSA1,4, Kaitlyn W Hess，MS，MLS（ASCP）CM，4，Natalie Johnson，PharmD4，David P Kao，MD1,3，Elizabeth L Kudro N，MD，MPH1，MPH1，3，Yee Ming Lee，Pharmd1，2 RN4，Anna Tanaka，BA1,4，Katy Trinkley，PharmD，PHD1，3，Sharon Vandenberg，RPH，MBA4，Christina L Aquil Ante，PharmD1，2